Protein Summary
Regulatory protein, which plays a central role in chromosome stability, in the p53/TP53 pathway, and DNA repair. Probably acts by blocking the action of key proteins. During the mitosis, it blocks Separase/ESPL1 function, preventing the proteolysis of the cohesin complex and the subsequent segregation of the chromosomes. At the onset of anaphase, it is ubiquitinated, conducting to its destruction and to the liberation of ESPL1. Its function is however not limited to a blocking activity, since it is required to activate ESPL1. Negatively regulates the transcriptional activity and related apoptosis activity of TP53. The negative regulation of TP53 may explain the strong transforming capability of the protein when it is overexpressed. May also play a role in DNA repair via its interaction with Ku, possibly by connecting DNA damage-response pathways with sister chromatid separation. The encoded protein is a homolog of yeast securin proteins, which prevent separins from promoting sister chr ...more
- ENST00000352433
- ENSP00000344936
- ENSG00000164611
- ENST00000393964
- ENSP00000377536
- ENST00000520452
- ENSP00000430642
- EAP1
- PTTG
- TUTR1
- EAP1
- PTTG
- HPTTG
- TUTR1
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
gene perturbation | 0.98 | ||
disease perturbation | 0.96 | ||
transcription factor perturbation | 0.88 | ||
biological process | 0.8 | ||
kinase perturbation | 0.71 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 365.49 (req: < 5)
Gene RIFs: 207 (req: <= 3)
Antibodies: 394 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 365.49 (req: >= 5)
Gene RIFs: 207 (req: > 3)
Antibodies: 394 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 12
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligand: 0
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0